A cancer drug sold by GlaxoSmithKline was shown in a clinical trial to extend by several months the length of time ovarian cancer patients lived without their disease worsening.
The findings suggest that the oral drug, Votrient, c
Two studies conducted in the US reported serious heart risks with GlaxoSmithKline Plc's diabetes pill Avandia while a third contradicted those findings, adding to a debate over whether the drug should stay on the market.
Saudi Arabia has suspended GlaxoSmithKline's diabetes drug Avandia for six months, arguing that potential heart risks outweigh its benefits.
The Saudi Food and Drug Authority (SFDA) was the first healthcare regulator to take such action. I
Two US drug safety reviewers have recommended that GlaxoSmithKline's diabetes drug Avandia be pulled from the market after concluding it is more dangerous to the heart than a rival medicine.
The Food and Drug Administration will again
A new vaccine showed promise at protecting young children from malaria, offering a potential new weapon against a disease that kills at least one million people each year, US researchers said.
In a study of 100 West African children aged o
GlaxoSmithKline hopes to seek approval by 2012 for its experimental vaccine to prevent malaria and will seek only a small profit on the product in order to make it widely available in hard-hit countries, the company said.
"(Its) sales in d
British drugmaker GlaxoSmithKline is currently Saudi Arabia's sole supplier of an H1N1 flu vaccine but the kingdom may include other firms for the supply of a nationwide inoculation campaign, the health ministry said.
GlaxoSmithKline has won US approval to sell a cervical cancer vaccine for girls and young women, while a rival Merck & Co shot was cleared for preventing genital warts in males.
Glaxo said the US Food and Drug Administration cleared th
GlaxoSmithKline said on Monday a single shot of its H1N1 swine flu vaccine protected people from the virus, adding to evidence that tight supplies can be stretched further by avoiding the need for two doses.
The British drugmaker is the la
GlaxoSmithKline and Pfizer, two leading developers of Aids drugs, are merging their HIV operations into a new company that will hold nearly a fifth of the market for treatments against the virus.
The two companies said on Thursday that Gla